Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
According to Endometriosis Network Canada, 1 in 10 women across the country are affected by endometriosis. To mark Endometriosis Awareness Month in March, we sat down with Dr. Sony Singh to discuss the disease and help break the stigma surrounding it.
According to Endometriosis Network Canada, 1 in 10 women across the country are affected by endometriosis. To mark Endometriosis Awareness Month in March, we sat down with Dr. Sony Singh to discuss the disease and help break the stigma surrounding it.
A new study from the University of Ottawa’s Faculty of Medicine found patients with mental or physical illness were able to successfully adhere to exercise regimes despite previous thinking, resulting in decreased suicide attempts.
A new study from the University of Ottawa’s Faculty of Medicine found patients with mental or physical illness were able to successfully adhere to exercise regimes despite previous thinking, resulting in decreased suicide attempts.
Dr. Kekre's early-career work has secured millions in funding and led to numerous peer-reviewed publications as she’s helped advance the immunotherapy field in Canada.
Dr. Kekre's early-career work has secured millions in funding and led to numerous peer-reviewed publications as she’s helped advance the immunotherapy field in Canada.
